Venture Capital

We've been fortunate lately. Despite the various indicators of a slowing economy, one thing that has not seen a downturn is the number of investments made by angels and angel groups here in the Midwest....

Swiss pharmaceutical company Roche Holdings is continuing its Madison buying spree by acquiring Madison-based Mirus Bio for $125 million. In this update: Mirus' funding model — no venture capital — the significance to Wisconsin's biotech industry, and Roche's possible intention to become the biggest biotech...

Whether your new business venture is technology oriented or not, there are lots of options available to an early stage company looking for money to fund its operations. This article is a summary of the basics of each type of financing, including some specifically geared...

In 2004, the nation took notice as California and Wisconsin independently announced major investments in stem cell and biotechnology research. Four years later—as a comparison to California, Maryland, Massachusetts and New Jersey shows—Wisconsin clearly has room to realize a better return on its investment....

Spurring more venture capital investment is considered essential to the state's economic growth, which is the justification for capital formation programs like the Act 255 investor tax credit program. The Wisconsin Department of Commerce has qualified two more technology companies, Perscitus Biosciences of Madison...

Count State Senator Pat Kreitlow as the latest to call for approval of venture capital expansion bills introduced in the Wisconsin Legislature. Kreitlow, a Chippewa Falls Democrat, has called for passage of legislation to expand tax credits and establish targeted tax exemptions as a way...